THOR Downgraded to Underperform - Analyst Blog
21 Mai 2013 - 9:30PM
Zacks
On May 20, 2013, we downgraded
Thoratec Corp. (THOR) to Underperform based on its
first quarter 2013 earnings results.
On May 2, Thoratec announced its
results for the reported quarter. The company reported
first-quarter 2013 adjusted earnings per share of 34 cents missing
the Zacks Consensus Estimate of 40 cents.
Revenues dropped 7% year over year
to $117.7 million in the first quarter, missing the Zacks Consensus
Estimate of $123 million. Geographically, domestic sales dropped
11.2% year over year to $92.3 million, while overseas sales
increased 10.9% to $25.4 million. By product, HeartMate sales
dropped 7.9% to $102.9 million.
Thoratec’s competitor
Heartware International Inc. (HTWR) received
approval in Nov 2012 from the FDA for its Ventricular Assist System
as a bridge to transplantation (BTT). Consequently, Thoratec has
lost market share in the BTT market leading to revenue shortfall.
However, there is no imminent competitive threat from HeartWare in
the Destination Therapy (DT) segment, as its product is not
expected to be launched in the near future.
Commercialization of next
generation HeartMate III is still some time away and HeartWare is
expected to close the gap. Thoratec continues to do well in
international markets although the base is small. In April 2013,
the company received reimbursement approval in Japan for HeartMate
II as a BTT treatment.
Over the past month, the Zacks
Consensus Estimate for 2013 has dipped 7.8% to $1.54. The Zacks
Consensus Estimate for 2014 has gone down 9.6% over the same
timeframe.
The stock carries a Zacks Rank #4
(Sell). We are more optimistic about Becton, Dickinson and
Company (BDX) which carries a Zacks Rank #2 (Buy) and is
expected to do well. In addition, Conceptus, Inc.
(CPTS) carries a Zacks Rank #1 (Strong Buy) and warrants a
look.
BECTON DICKINSO (BDX): Free Stock Analysis Report
CONCEPTUS INC (CPTS): Free Stock Analysis Report
HEARTWARE INTL (HTWR): Free Stock Analysis Report
THORATEC CORP (THOR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024